HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stada To Market 50 Sanofi Brands Across Europe

Executive Summary

Germany's Stada is strengthening its portfolio by taking over distribution of 50 well-established Sanofi Consumer Healthcare brands marketed across Europe.

You may also be interested in...

EU Business News: Nestlé Cuts L'Oréal Stake, Stada Sets Up In Sweden

The latest news from Europe's health, beauty and wellness markets: Nestlé is reducing its stake in L'Oréal to fund an expanded share buyback program; and Stada has opened in office in Sweden to manage the distribution and marketing of a portfolio of well-established Sanofi brands.

Stada Expands Portfolio In US And Nordics As First-Half Sales Rise

Stada reported Branded Products sales up 9% in the first half as it secured two additions to its portfolio, with a US dietary supplement brand and Nordic herbal analgesic.

Sanofi's Focus On Priority Categories Bears Fruit In Second Quarter

Sanofi says a double-digit gain for its Consumer Healthcare business in Q2 is evidence its new category prioritization strategy is paying off.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts